Condition: Idiopathic Pulmonary Fibrosis (IPF) · Progressive Pulmonary Fibrosis · Sponsor: Royal Brompton & Harefield NHS Foundation Trust
To assess the impact on body mass composition from anti-fibrotic medications used in fibrotic lung disease by using BIA and muscle ultrasound
This description comes directly from the study's public registry record.
Jessica Dr Raja · 07955229245 · jessica.raja2@nhs.net
Elisabetta Professor Renzoni · elisabetta.renzoni@nhs.net
Always discuss trial participation with your own doctor first.
| Royal Brompton Hospital | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07332117